arrow
R

Rainer Hamacher

university of duisburg essen
H指数:23
被引数:1,905

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nilotinib revisited in GIST: salvage use in patients with severe imatinib toxicity

尼洛替尼在胃肠间质瘤中的重新评估:严重伊马替尼毒性患者的挽救性应用

2026-09-030
OAAI
Diagnostic value of [68Ga]Ga-FAPI-46 PET in comparison to [18F]FDG PET in triple-negative breast cancer and potential for theranostic application

三阴性乳腺癌中[68Ga]Ga-FAPI-46 PET与[18F]FDG PET的比较诊断价值及其治疗诊断应用潜力

2026-08-030
OA
Variations in surgical strategies and treatment allocation for retroperitoneal sarcomas across German-speaking sarcoma centres

德语区肉瘤中心在腹膜后肉瘤的手术策略和治疗分配方面的差异

EJSO
IF2.9
2026-08-010
PRE
Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer

[68Ga]Ga-FAPI-46与[18F]FDG PET/CT摄取在腔面型与HER2阳性乳腺癌中的比较

2026-03-130
OA
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy

曲贝替定联合靶向CD13的组织因子tTF-NGR治疗晚期复发或难治性软组织肉瘤:转化数据、临床安全性和有效性

2026-02-190
OAAI
[68Ga]Ga-FAPI-46 PET/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[18F]FDG PET/CT and Contrast-Enhanced CT: Results from a Prospective Observational Study

Bartel, T.; Pabst, K.M.; Barg, C.; Berliner, C.A.; Hamacher, R.; Bauer, S.; Falkenhorst, J.; Kessler, L.; Nader, M.; Barbato, F.; 等. [(68)Ga]Ga-FAPI-46 PET/CT在胃肠间质瘤患者中的应用,与2-[(18)F]FDG PET/CT及增强CT的比较:一项前瞻性观察研究的成果. J. Nucl. Med. 2025, 67, 210–216. [Google Scholar] [CrossRef]

2026-02-012
PRE
Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/ 5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial

PAMSARC(在表达SSTR2/3/5的滑膜肉瘤和弥漫性小圆细胞瘤中使用帕西瑞肽作为每月深部肌肉注射的维持治疗)多中心II期试验的原理与设计

2025-09-010
OAAI
[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial

[68Ga]Ga-FAPI-46 PET在肿瘤成像中的准确性及组织病理学验证:一项单中心、单臂、干预性、II期试验

2025-08-040
OAAI
CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial

CDK4/6抑制剂在晚期软骨肉瘤中的应用:NCT PMO-1601试验的最终结果

2025-07-070
OA
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (vol 151, 30, 2024)

软组织肉瘤环状试验:一项基于病例的分析,评估德国21个讲德语的软组织肉瘤中心之间的中心间一致性(卷151,期30,2024)

2025-04-240
OA
Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability (vol 150, 489, 2024)

携带KIT突变转移性GIST患者在接受多种激酶抑制剂治疗时代的总生存期(vol 150, 489, 2024)

2025-01-110
OA
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [68Ga]Ga-/[18F]F-PSMA-11/-1007, [68Ga]Ga-FAPI-46 and 2-[18F]FDG PET/CT: a pilot study
2024-08-291
OAAI
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity
2024-08-012
OAAI
Fibroblast Activation Protein-Directed - Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
2024-07-031
PRE
Homologous recombination repair (HRR) deficiency in biliary tract cancers: Clinical implications in subsequent therapy lines and correlation with platinum sensitivity
2024-06-010
PRE
Prognostic Implications of 68Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors
2024-05-232
PRE